Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There is no evidence. Hope remains a powerful emotion. And if you’ve invested so much of yourself in a particular belief, you’re going to always look for the positives even when there aren’t any. This is simple human nature. Missling counts on this to keep his flock in line.
I’m not being negative. I’m just stating a fact. A Monday presentation at 8:45 is not going to get a big audience. But if it makes you feel better, how about this?
Monday at 8:45 is a fantastic time slot. Investors will be fresh off the weekend and eager to hear a great story. Once they hear Missling’s presentation, the rest of the presentations will be downhill from there. It’s also great that the conference is virtual and won’t be limited to a smaller audience attending the conference in person. With the Needham conference being virtual, there could be hundreds if not thousands of investors in the U.S., Europe and Asia tuning in to hear the best Alzheimer’s/CNS opportunity ever (and certainly more promising than any other approach in development). I expect Missling to issue ABSOLUTELY HUGE NEWS prior to the presentation, which should attract even more viewers (maybe even worldwide health journalists). The 8th is what could blow the roof off, with the stock likely to at least double or maybe even 5X.
Lousy presentation day/time. A Monday morning at 8:45 Eastern means 7:45 Central, 6:45 Mountain, and 5:45 on the West coast. I don’t expect too many investors will be tuning in, especially on the West coast, though the WGTers will be on.
Why Needham even invited Anavex is beyond me.
The evidence of fraud seems pretty clear based on my reading. People love to dump on Adam Feuerstein except when he says something positive. Then he’s a great journalist.
The truth can be painful when you’ve staked your credibility on a sketchy CEO with a track record worthy of an Edsel.
“If he has been lying to us”
IF he’s been lying to us? IF he’s been obfuscating?
I think we know the answer.
You forgot one. Missling is fired.
Right. And I saw clouds in the sky today that I swear looked like Missling. Amazing how easy it is to see something where there is nothing.
That is a FACT.
You need to come up with a couple of new go-to excuses. The paint-the-tape thing has gotten old. I know you can do it!
I don’t engage in conspiracy theories. I think the belief that regulators and big pharma companies are somehow conspiring against Anavex is a cop out. There is a long history of biotech companies that started out in a lab someplace developing and commercializing breakthrough drugs. Look back at the history of Alexion as an example.
If you can cite a single instance, with verifiable evidence, please enlighten us.
A constant theme here is making all kinds of crazy excuses to let Missling off the hook (even as it costs shareholders dearly). The belief that regulators and big pharma are conspiring to suppress Anavex is just one of many excuses. Missling has established a cult-like following that obviously cannot even entertain the possibility that he is not the god that some imagine him to be (or perhaps David fighting Goliath).
Small, well managed biotech companies with breakthrough science have and will continue to drive innovation and commercialize breakthrough drugs. Some will succeed and some will fail. None will fail because of a wild conspiracy theory. Again, look at the history of Alexion as but one example.
I will ask you the same question I have asked others: If you really believe that regulators and big pharma conspire against small biotechs like Anavex, why on Earth do you invest in biotech? After all, there are other ways to invest your money where you can hopefully have more confidence in the integrity of the players.
Up 3 cents on less than a million shares tells any rational shareholder that the market does not anticipate any ABSOLUTELY HUGE NEWS (or any news for that matter) anytime soon.
Nice try but it falls flat.
The days of AVXL being a meme stock are over. Just accept it. Missling has disappointed investors too many times. The stock is no longer a story stock. It’s a “show me” stock unless and until there is actually significant news.
Utter nonsense. He sold because he knows there is ABSOLUTELY NO HUGE NEWS coming anytime soon.
C’mon George. ALS isn’t even in the pipeline.
Apparently Missling doesn’t agree with you. If he did, he’d have waited until May to exercise his options and sell the shares.
Think before you pump.
(All of my comments are provided by my cabal handlers and approved by Adam F).
If Missling was optimistic (or knew something we don’t) he could have waited until May and then exercised his options and held the underlying shares and paid the taxes. He certainly could afford to do so.
(All my comments are supplied by my handlers).
These options exercises and sales at $5.06 don’t speak well for Missling’s outlook for the future. Apparently he’s not waiting with bated breath for the peer-reviewed paper, EMA filing, or much of anything else.
(P.S. - Adam Feuerstein instructed me to post this).😂
What a terrible world we live in! So many big guys (and gals) out to get the little guys (and gals). It’s a wonder we can make it through an ordinary day in one piece.
So many conspiracy theories inferring facts with no evidence.
Sounds like twisted logic to me.
Do you really expect this leopard to change his spots?
I think deep down you know he won’t.
It amazes me how so many here see the stock market as totally corrupt yet they continue to invest in stocks.
That’s what you predicted the Friday before last and the fort night before that. This was after predicting early in the year that all of your 2024 predictions would come true.
Here’s a press release issued today that I hope we will see someday soon from Anavex:
https://ir.energous.com/news-events/press-releases/detail/785/energous-announces-leadership-change
I admire your optimism and hope you’re right. Having said that, I would suggest doing a deep dive into his background pre-Anavex and his track record of stumbles, fumbles, goal post moving, cherry picking of data, and horrible communications since joining Anavex. Good luck with your investment.
I agree with much of what you said but that does not change my view that Missling has demonstrated incompetence, has damaged the company’s credibility, and has train-wrecked shareholder value. The extraordinary challenges of biotech demand highly competent management and credibility is especially important. In my opinion, new, seasoned leadership with demonstrated success in the field, is more important than ever. We deserve better than we’ve gotten.
Thank goodness for some common sense.
The only funds that own AVXL are index funds. You obviously have no idea how index funds operate. Nice try at pumping though.
Sounds like a financial suicide strategy to me.
Missling doesn’t care. Any why should he? He’s protected by his buddies on the BOD. I just read an article that the problems at Boeing have led to the CEO of Boeing stepping down at the end of 2024 and the head of the commercial plane division leaving immediately. Also, the chairman of the board will not stand for re-election. So yes, it is possible for there to be consequences when bad things happen. While Anavex is not Boeing, the damage Missling has wrought on shareholders is just as bad or worse in its own way and yet there are no consequences.
Thanks George. Queue the irrational exuberance and endless speculation about the huge news that could be disclosed at Needham only to be let down when the same old presentation is given.
That’s a joke, right?
In my opinion and my experience, Missling appears uniquely unqualified. There’s just too much smoke for there not to be fire.
There’s no indication he’s going away anytime soon, so I guess we’ll know when we know.
This gets really tiresome but let me try again. Speaking for myself, I am not a short seller. I have a long position in AVXL. I am not a day trader. I believe the science underlying Anavex is interesting and has potential. My concern is with our CEO and the board members who coddle him. My frustration is that I believe, based on my professional experience, that our CEO is incapable of driving toward success. I don’t believe he has the skills, temperament, or experience to enhance shareholder value. I believe that shareholders (and patients) would be better served by a CEO who has a track record of success in drug development, business development, regulatory affairs, and commercialization, and also someone who is respected within the investment community. Our CEO has badly damaged his and our company’s credibility to the point where he is a serious liability and impediment to future success.
Maybe you think Missling is a great CEO and you have complete confidence in him. If so, good for you. I happen to disagree. I’d like to see a change in management and a makeover of the BOD. I think if a competent CEO with a proven track record was brought in to replace Missling, the stock would be higher. A competent CEO with credibility among biotech investors would be a very positive development.
As a shareholder, I’ll continue to advocate for a change at the top and at the board level.
Anavex looks to be in a death spiral. Will the board let the company slowly go down the drain or will they finally toss Missling overboard and bring in competent management in order to protect and enhance shareholder value?
Here’s the good news: The stock is unlikely to trade below its cash per share of $1.80 at 12/31.
My guess is there has been additional dilution in Anavex’s 2nd fiscal quarter (2Q ends 3/31) since Missling is spending a lot and doesn’t like cash on hand to fall below $150 million.
“…it has to be market manipulation in order for the big guys to acquire cheap shares. The continual climb of institutional shares proves that!”
Wrong on both counts. On the first count, this is a classic conspiracy theory. This is not how it works. Real institutional investors are happy to pay up for a de-risked security. They are not bottom fishers like your typical retail investor. On the second count, read here as to why the index funds that own AVXL are adding shares. https://www.investopedia.com/terms/i/indexfund.asp#:~:text=The%20portfolios%20of%20index%20funds,matched%20with%20the%20target%20index.
AVXL is breaking down. It’s been breaking down since the disastrous CTAD meeting in December 2022. The stock could be trading at cash in a matter of days or weeks. Look out below.
As of the end of the first fiscal quarter (Dec. 31), Anavex had 82 million shares outstanding and $148 million in cash. That’s $1.80 in cash per share. That means the market is valuing Anavex (patents, pipeline, clinical trials, etc.) at just $2.86 a share.
Dry Power Man is back and ready to reload! Must be new money since your losses have been heavy.
Your investment group must be thrilled! Haha.
Too bad neither he nor his directors are listening.
What we’ve seen so far is not encouraging but time will tell. I’d love to be wrong.
By the way, behemoth companies don’t necessarily pay better than small companies, or maybe Jin preferred to be a big fish in a small pond. People take jobs for all kinds of reasons but not necessarily because they are absolutely convinced of future success. Again, we really don’t know what his motives were nor what his current thinking is. Making assumptions in the absence of evidence is risky.
Here’s a fact: AVXL is in the toilet because Missling is an incompetent CEO who has zero credibility. Everyone except a relative handful of message board cult followers and conspiracy theorists knows it.